SNN0031

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	3

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01829867 (ClinicalTrials.gov)	April 2013	9/4/2013	A Study With an Increased Dose Step in Patients That Have Previously Received Placebo or sNN0031.	A Phase I, Open-label Study in Patients With Parkinson's Disease to Further Assess Safety and Tolera ...	Parkinson's Disease	Drug: sNN0031	Newron Sweden AB	NULL	Terminated	55 Years	75 Years	Both	5	Phase 1	Sweden
2	NCT00866502 (ClinicalTrials.gov)	March 2009	18/3/2009	A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0031to Patients With ...	A Randomized, Double-blind, Placebo Controlled, Safety and Tolerability Study of Intracerebroventric ...	Parkinson's Disease	Drug: sNN0031;Drug: Placebo	Newron Sweden AB	Medtronic;Quintiles	Completed	30 Years	75 Years	Both	12	Phase 1/Phase 2	Sweden
3	EUCTR2007-007853-30-SE (EUCTR)	28/01/2009	21/12/2007	A randomized, double-blind, placebo controlled, safety and tolerability study of intracerebroventric ...	A randomized, double-blind, placebo controlled, safety and tolerability study of intracerebroventric ...	Idiopathic Parkinson's disease (PD) of moderate severity (modified Hoehn & Yahr Stage IIb - III)	Product Name: sNN0031 Product Code: sNN0031	NeuroNova AB	NULL	Not Recruiting			Female: yes Male: yes			Sweden

First Previous1Next Last